Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2018        Go!    
 
 
February 23, Friday 2018 12:13 PM       

       HEADLINES: One burnt to death as car catches fire                                              No one would speak out since Madhu was killed in ‘No. 1 Kerala’: K Surendran                                              People behind my son’s murder must be caught: Madhu’s mother                                              Parambikulam-Aliyar issue: Vehicles blocked at TN-Kerala border                                              After 70 years of Independence electricity reaches Elephanta Caves                                              Why should I respond? Nirmala Seetharaman on Army chief’s comment                                              Khalistani terrorist invited for Trudeau reception                                              Canadian MP apologises for inviting Atwal to Trudeau's dinner                                              Grenade hurled at US embassy in Montenegro                                              Trump pledges to find long-term solution to gun violence                                              Ish Sodhi named in Kiwi ODI squad                                              Kalu Uche's late strike helps Dynamos hold Goa to 1-1 draw                                              ISL: Mumbai City look to keep semi-final hopes alive                                              Kaumudi Facebook
       SCI&TECH Next Article: New potent vaccine may spell end for HIV  
       Predatory bacteria may wipe out 'superbugs': study
 
         Posted on :20:02:53 Nov 28, 2016
   
A A
       Last edited on:20:02:53 Nov 28, 2016
         Tags: Predatory bacteria, superbugs
 
LONDON: Predatory bacteria - that eat others of their kind - could be a new weapon in the fight against drug-resistant bacteria or 'superbugs', a new study suggests.
 
A naturally occurring predatory bacterium is able to work with the immune system to clear multi-drug resistant Shigella infections in zebrafish, researchers from Imperial College London and Nottingham University in the UK said.
 
It is the first time the predatory bacterium Bdellovibrio bacteriovorus has been successfully used as an injected anti-bacterial therapy and represents an important step in the fight against drug-resistant infections, or 'superbugs'.
 
Shigella infection is responsible for over 160 million illnesses and over one million deaths every year - and is a common cause of travellers' diarrhoea.
 
Cases of drug-resistant Shigella are also on the rise as, although the diarrhoea usually clears up without treatment, antibiotics are often used even in mild cases to stop the diarrhoea faster.
 
To investigate Bdellovibrio's ability to control drug resistant Gram-negative infections, researchers injected zebrafish larvae with a lethal dose of Shigella flexneri strain M90T, resistant to both streptomycin and carbenicillin antibiotics.
 
Bdellovibrio was injected into the larvae's infection site and a decrease in the number of Shigella was seen.
 
In the absence of Bdellovibrio, zebrafish were unable to control the replication of Shigella and levels of the bacteria rose.
 
"This study really shows what a unique and interesting bacterium Bdellovibrio is as it presents this amazing natural synergy with the immune system and persists just long enough to kill prey bacteria before being naturally cleared," said Serge Mostowy, from Imperial College London.
 
"It's an important milestone in research into the use of a living antibiotic that could be used in animals and humans," Mostowy said.
 
Bdellovibrio can invade and kill a range of Gram-negative bacteria, such as E coli and Salmonella, in the natural environment.
 
Previous research has shown that it can reduce pathogen numbers in the stomach of chickens when taken as an oral therapy, but there is growing need to develop therapies to target infections in wounds and organs.
 
Successful use of Bdellovibrio highlights its potential uses in tackling a range of drug-resistant Gram-negative bacterial infections that can develop in hospital patients.
 
"This has been a truly ground-breaking collaboration that shows therapeutic Bdellovibrio in action inside the translucent living zebrafish," Professor Liz Sockett, from The University of Nottingham said.
 
"The predatory action of the Bdellovibrio breaks the Shigella-pathogen cells and this stimulates the white blood cells; redoubling their 'efforts' against the pathogen and leading to increased survival of the zebrafish 'patients'," said Sockett.
 
The study was published in the journal Current Biology.
A A
       SCI&TECH
Next Article: New potent vaccine may spell end for HIV
 
 
SCI&TECH HEADLINES
Ensuring sexual, reproductive health for overall well-being  
WeChat gets popular in Bhutan: report  
Celebrate love this Valentine's Day with Google Pixel 2  
This drug could reverse alcohol's damaging effects on brain  
Scientists discover enormous reserves of mercury in permafrost  
Google Assistant helps you set music alarms  
What is epilepsy?  
Here're some ways to keep dementia at bay  
What are memories made of?  
Second-hand plastic toys could harm your kid  
Working before and after stroke is good for brain health  
ixigo introduces India's first augmented reality feature for Train Passengers  
Super blue moon on Jan. 31 will mark last of trilogy  
Now, a blood test that can screen eight cancer types  
Secret of longevity protein revealed!  
Absence of this gene can give men deadly cancer  
Soon, you can demote group admins on WhatsApp  
Regular yoga can slow down ageing of brain: Study  
What are haemorrhoids (piles) and what causes them?  
WhatsApp facilitates quick switch from voice to video call  
The Thin and Light Lenovo Ideapad 720s shines at Digit Zero 1 Awards  
Frequent heartburns up cancer risk in older adults  
Blueberry vinegar can help fight dementia  
iPhones with older batteries will take a hit in performance: Apple  
Eighth planet found in faraway solar system, matching ours  
 
Do you think Kamal Haasan's party will be a success in Tamil Nadu politics?
Yes
 
No
 
No opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy